Natriuretic peptides: Biomarkers not predictive in the intensive care unit

Critical Care Medicine

Volumn 35, Issue 4, 2007, Pages 1194-1195

  Ginsberg, Fredric ^a   Topalian, Simon ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

B type natriuretic peptide; Biomarkers; N terminal pro B type natriuretic peptide; Natriuretic peptides; Sepsis and septic shock; Sepsis associated myocardial dysfunction

Indexed keywords

BIOLOGICAL MARKER; HYPERTENSIVE FACTOR; NATRIURETIC FACTOR;

ARTIFICIAL VENTILATION; DEPRESSION; EDITORIAL; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTENSIVE CARE UNIT; PRIORITY JOURNAL; PROTEIN SECRETION; SEPSIS; SEPTIC SHOCK;

BIOLOGICAL MARKERS; HUMANS; INTENSIVE CARE UNITS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEPSIS; SHOCK, SEPTIC;

EID: 34247101612     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000260056.54558.29     Document Type: Editorial

References (15)

1. McCullough PA, Nowak RM, McCord J, et al: B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106:416-422
2. Mueller C, Scholer A, Laule-Kilian K, et al: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Eng J Med 2004; 350:647-654
3. Januzzi JL, van Kimmenade R, Lainchbury J, et al: NT-pro BNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients. The International Collaborative of NT-pro BNP Study. Euro Heart J 2006; 27:330-337
4. DeLemos JA, Morrow DA, Bentley JH, et al: The prognostic value of B-natriuretic peptide in patients with acute coronary syndromes. N Eng J Med 2001; 345:1014-1021
5. Iwanga Y, Nishi I, Furuichi S, et al: B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47:742-748
6. Jaffe AS, Babuin L, Apple FS: Biomarkers in acute cardiac disease: The present and the future. J Am Coll Cardiol 2006; 48:1-11
7. Nohria A, Givertz MM: B-type natriuretic peptide and the stressed heart. J Am Coll Cardiol 2006; 47:749-751
8. Maeder M, Fehr T, Rickli H, et al: Sepsis-associated myocardial dysfunction. Chest 2006; 129:1349-1366
9. McLean AS, Huang SJ, Hyams S, et al: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35:1019-1026
10. Forfia PR, Watkins SP, Rame E, et al: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005; 45:1667-1671
11. Rudiger A, Gasser S, Fischler M, et al: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006; 34:2140-2143
12. Tung RH, Garcia C, Morss AM, et al: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004; 32:1643-1647
13. 2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005; 33:1001-1007
14. Januzzi JL, Morss A, Tung R, et al: Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: A prospective cohort study. Crit Care Med 2006; 10:R37
15. Cuthbertson BH, Patel RR, Croal BL, et al: B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 2005; 60:16-21